cdmo.directory
← Compare landing

重庆兴泰濠制药有限公司 (Sintaho) vs Veranova

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/sintaho/veranova

Category重庆兴泰濠制药有限公司 (Sintaho)Veranova
Listed sitecdmocdmo
SummaryChina-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.Global CDMO specializing in development and manufacturing of complex active pharmaceutical ingredients (APIs), with expertise in solid form sciences, process development, and specialty modalities including ADCs and controlled substances.
Services
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Peptide Manufacturing
  • Small Molecule Development & Manufacturing
  • CMC Analytical Development
  • Process Development
  • Technology Transfer
  • Formulation Development
  • Solid-State Chemistry & Polymorph Screening
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • ADC Payload & Linker Synthesis
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
Modalities
  • Small Molecule
  • Peptide
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Chongqing, Chongqing, China
Data not yet provided.
Certifications
  • Internet Drug Information Service Qualification (Chongqing) · Identifier: （渝）-非经营性-2022-0020
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.